Thaise Gonçalves Araújo*, Lara Vecchi, Paula Marynella Alves Pereira Lima, Everton Allan Ferreira, Igor Moreira Campos, Douglas Cardoso Brandão, Gabriela Silva Guimarães, Matheus Alves Ribeiro and Ademar Alves da Silva Filho Pages 6628 - 6642 ( 15 )
Triple Negative Breast Cancers (TNBC) are heterogeneous and aggressive pathologies, with distinct morphological and clinical characteristics associated with their genetic diversity, epigenetics, transcriptional changes and aberrant molecular patterns. Treatment with anti-neoplastic drugs exerts systemic effects with low specificity, and incipient improvement in overall survival due to chemoresistance and recurrence. New alternatives for TNBC treatment are urgent and parthenolide or its analogues have been explored. Parthenolide is a sesquiterpene lactone with promising antitumor effects against TNBC cell lines. This review highlights the importance of parthenolide and its analogue drugs in TNBC treatment.
Parthenolide, triple negative breast cancer, sesquiterpene lactones, nuclear factor-κB, heterogeneity, natural products.
Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Minas Gerais, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Minas Gerais, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Minas Gerais, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Minas Gerais,, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Minas Gerais,, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia, Minas Gerais,, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais